The present invention relates to a foam formed solid composite, comprising: a matrix phase consisting of a mixture of nanocellulose, at least one foaming agent, and optional additives, and a dispersed phase consisting of solid low-density particles having a density of less than 1.2 kg/dm.sup.3. The present invention further relates to a method and a liquid foam composition for manufacturing the solid composite.

A microfibrillated cellulose-loaded foam is indicated, comprising microfibrillated cellulose, at least one thickening agent and/or at least one adhesive biopolymer. Furthermore, a method for producing such a microfibrillated cellulose-loaded foam and a use of such a foam are provided.

To provide a rubber composition excellent in elasticity and low loss property.

A rubber composition comprising 100 parts by weight of a chloroprene rubber and from 1.2 to 3.0 parts by weight of cellulose nanofibers, characterized in that a vulcanized sheet obtained by vulcanizing the rubber composition has a 100% tensile stress (M100) increased by 1.5 MPa or more per part by weight of the cellulose nanofibers added, where the increase of M100 is calculated by subtracting M100 of a vulcanized sheet containing no cellulose nanofibers from M100 of the vulcanized sheet containing the cellulose nanofibers, and dividing the difference by the amount of the cellulose nanofibers contained.

A water- and oil-proofing composition which can provide an article with high utility oil resistance is provided. A water- and oil-proofing composition comprising a fluorinated polymer comprising units based on the following monomer (a) and units based on the following monomer (b), a fatty acid ester of polyglycerin and an aqueous medium: Monomer (a): a compound represented by CH.sub.2═CH—R.sup.f (wherein R.sup.f is a C.sub.1-8 perfluoroalkyl group). Monomer (b): a monomer copolymerizable with the monomer (a).

The present invention relates to the treatment or prevention of skeletal disorders, in particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

The present invention relates to biodegradable and compostable granules consisting of natural ingredients comprising starch and thickening and gelling agents and does not comprise bioplastics. According to the invention, the granules are used for producing biodegradable and preferably compostable products and articles of daily use. The present invention also relates to methods for producing the granules according to the invention, as well as methods for producing different products by using the granules according to the invention.

A polyimide precursor-containing aqueous composition contains at least one polymer material selected from the group consisting of a water-insoluble fibrous organic substance and a polyalkylene oxide having a viscosity-average molecular weight of 5 million or more, a polyimide precursor, particles, and water.

A method of making a foam comprising the following steps. A mixture is created comprising (i) a first reactant comprising triglyceride having acrylate functionality, (ii) a second reactant comprising diacrylate, and (iii) a blowing agent. The mixture is expanded to create a froth. The first and second reactants of the froth are reacted to create the foam.

The present invention relates to the treatment or prevention of skeletal disorders, at particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.

The present invention relates to the treatment or prevention of skeletal disorders, at particular skeletal diseases, developed by patients that display abnormal increased activation of the fibroblast growth factor receptor 3 (FGFR3), in particular by expression of a constitutively activated mutant of FGFR3.